EXAGEN INC. Cash and Cash Equivalents
EXAGEN INC. (XGN) had Cash and Cash Equivalents of $24.59 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-04
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $24.59M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $21.51M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $32.22M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $35.65M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $24.59M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $21.51M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $32.22M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $35.65M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $30.03M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $11.19M 10-Q · filed 2025-05-05 |
| 2024-12-31 | $22.04M 10-K · filed 2026-03-10 |
| 2024-09-30 | $22.04M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $24.48M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $27.27M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $36.49M 10-K · filed 2025-03-11 |
| 2023-09-30 | $28.45M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $31.47M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $52.18M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $62.39M 10-K · filed 2024-03-18 |
| 2022-09-30 | $68.70M 10-Q · filed 2022-11-21 |
| 2022-06-30 | $76.39M 10-Q/A · filed 2022-11-21 |
| 2022-03-31 | $89.75M 10-Q · filed 2023-05-15 |
| 2021-12-31 | $99.44M 10-K · filed 2023-03-20 |
| 2021-09-30 | $106.77M 10-Q · filed 2022-11-21 |
| 2021-06-30 | $112.58M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $118.05M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $57.45M 10-K · filed 2022-03-22 |
| 2020-09-30 | $61.43M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $63.70M 10-Q · filed 2020-07-28 |
| 2020-03-31 | $68.65M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $72.08M 10-K · filed 2021-03-16 |
| 2019-09-30 | $77.83M 10-Q · filed 2019-11-12 |
| 2018-12-31 | $13.16M 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |